4Q15 4Q14 % Change Million EUR 12M15 12M14 % Change

Size: px

Start display at page:

Download "4Q15 4Q14 % Change Million EUR 12M15 12M14 % Change"

Cynthia Sparks
5 years ago
Views:

5 4Q15 4Q14 % Change Million EUR 12M15 12M14 % Change % Revenue Group 1, , % Revenue Other segment % Revenue at comparable scope 1, , % % Rebitda Group % Rebitda Other segment % Rebitda at comparable scope % Rebit Group % - Rebit Other segment Rebit at comparable scope % Profit (+) / loss (-) for the period % Total comprehensive income for the period % Cash flow from operating activities minus capital expenditure % Net debt Notional net debt

8 180.4mEUR Industrial solutions 28.6% Agro 1,589.0 meur 40.6% 76.9% Agro Biovalorization 30.7% 23.7% Industrial solutions 0.0% -0.7% Bio-valorization

9 AGRO Million EUR 12M15 12M14 % change Revenue % REBITDA % REBITDA margin 21.5% 19.0% - REBIT % REBIT margin 17.9% 15.4% -

10 BIO-VALORIZATION Million EUR 12M15 12M14 % change Revenue % REBITDA nm REBITDA margin -0.2% 1.3% - REBIT nm REBIT margin -6.1% -4.8% -

11 INDUSTRIAL SOLUTIONS Million EUR 12M15 12M14 % change Revenue % REBITDA % REBITDA margin 9.4% 7.2% - REBIT % REBIT margin 4.1% 2.0% -

12 REBIT FY15 Non-recurring items EBIT Net finance costs Income Tax Expense Share of result of investments PROFIT FY15 (27.3) 8.1 (7.2) (6.7)

13 3.3. CONSOLIDATED STATEMENT OF FINANCIAL POSITION Million EUR ASSETS Total non-current assets Property, plant and equipment Goodwill Other intangible assets Investments accounted for using the equity method Other investments Deferred tax assets Trade and other receivables Derivative financial instruments Total current assets Inventories Trade and other receivables Derivative financial instruments Cash and cash equivalents Non-current assets classified as held for sale Total assets 1, ,185.4

14 Million EUR EQUITY AND LIABILITIES Total equity Equity attributable to equity holders of the company Non-controlling interest Total liabilities Total non-current liabilities Financial liabilities Employee benefits Provisions Trade and other payables Derivative financial instruments Deferred tax liabilities Total current liabilities Bank overdrafts Financial liabilities Trade and other payables Derivative financial instruments Current tax liabilities Employee benefits Provisions Total equity and liabilities 1, ,185.4

15 CONSOLIDATED STATEMENT OF CASH FLOWS Million EUR OPERATING ACTIVITIES Profit (+) / loss (-) for the period Depreciation, amortization and impairment losses on tangible assets, goodwill and other intangible assets Impairment losses on other investments Impairment losses on disposal groups Changes in provisions Revaluation electricity forward contracts Finance costs Finance income Loss / (profit) on sale of non-current assets Share of result of equity accounted investees, net of income tax Income tax expense Other non-cash items Changes in inventories Changes in trade and other receivables Changes in trade and other payables Change in accounting estimates - inventory write off Cash generated from operations Income tax (paid)/received Dividends received Cash flow from operating activities

16 INVESTING ACTIVITIES Acquisition of property, plant and equipment Acquisition of other intangible assets Acquisition of businesses, net of cash acquired Subsequent consideration paid - acquisition Acquisition of investments, net of cash acquired Proceeds from the sale of property, plant and equipment Proceeds from the sale of other intangible assets Proceeds from the sale of subsidiaries, net of cash disposed of Proc. from the sale of investments accounted for using the eq. method Proceeds from the sale of other investments Capital decrease from other investments Capital decrease from investments accounted for using the eq. method Cash flow from investing activities FINANCING ACTIVITIES Increase of issued capital - issuance new shares Increase of issued capital - conversion of warrants Costs capital increase Capital increase from non-controlling interests Change in non-recourse factoring and securitization Proceeds from new borrowings (Reimbursement) of borrowings Cash movement resulting from settlement financial instruments Interest paid Interest received Other finance costs paid (Increase) of long term receivables Decrease of long term receivables Cash flow from financing activities Net increase / (decrease) in cash and cash equivalents Effect of exchange rate differences Cash and cash eq. less bank overdrafts at the beginning of the period Cash and cash eq. less bank overdrafts at the end of the period

18 Tessenderlo Group is a worldwide specialty company, focused on food, agriculture, water management and on valorizing bio-residuals. The group employs about 4,800 people and is a leader in most of its markets, with a consolidated revenue of 1.6 billion EUR in Tessenderlo Chemie NV is listed on NYSE Eurolist by Euronext Brussels and is part of Next 150 and BEL Mid indices. Financial News wires: Bloomberg: TESB BB Reuters: TesBt.BR Datastream: B:Tes 2015 Results February 16, 2016

2Q15 2Q14 % Change Million EUR HY15 HY14 % Change

2Q15 2Q14 % Change Million EUR HY15 HY14 % Change 444.3 379.3 17.1% Revenue Group 850.1 775.7 9.6% - -1.4 - Revenue Other segment - -31.2 444.3 377.9 17.6% Revenue at comparable scope 850.1 744.5 14.2%